Literature DB >> 17602994

Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition.

Lars Arendt Nielsen1, Karl G Henriksson.   

Abstract

Chronic musculoskeletal pain has biological, psychological and social components. This review deals with the biological factors, with emphasis on the fibromyalgia syndrome (FMS). Studies on central sensitization of pain-transmitting neurons, changes in endogenous pain modulation that give rise to pain disinhibition, referred pain, pain-related decrease in muscle strength and endurance, and pain generators in deep tissues are reviewed. In FMS there is strong scientific support for the statement that the biological part of the syndrome is a longstanding or permanent change in the function of the nociceptive nervous system that can be equated with a disease. Further research is necessary in order to determine which methods are best for diagnosis of the pain hypersensitivity in clinical practice. FMS may be the far end of a continuum that starts with chronic localized/regional musculoskeletal pain and ends with widespread chronic disabling pain.

Entities:  

Mesh:

Year:  2007        PMID: 17602994     DOI: 10.1016/j.berh.2007.03.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  36 in total

1.  Mechanical and heat hyperalgesia highly predict clinical pain intensity in patients with chronic musculoskeletal pain syndromes.

Authors:  Roland Staud; Elizabeth E Weyl; Donald D Price; Michael E Robinson
Journal:  J Pain       Date:  2012-06-26       Impact factor: 5.820

Review 2.  Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

Review 3.  Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria.

Authors:  John McBeth; Matthew R Mulvey
Journal:  Nat Rev Rheumatol       Date:  2012-01-24       Impact factor: 20.543

Review 4.  Exploring the central modulation hypothesis: do ancient memory mechanisms underlie the pathophysiology of trigger points?

Authors:  Mark J L Hocking
Journal:  Curr Pain Headache Rep       Date:  2013-07

Review 5.  The role of vitamin D in pathophysiology and treatment of fibromyalgia.

Authors:  Carlos A S Jesus; David Feder; Mario F P Peres
Journal:  Curr Pain Headache Rep       Date:  2013-08

6.  Injectable nanocomposite analgesic delivery system for musculoskeletal pain management.

Authors:  Manakamana Khanal; Shalini V Gohil; Emmanuel Kuyinu; Ho-Man Kan; Brittany E Knight; Kyle M Baumbauer; Kevin W-H Lo; Joseph Walker; Cato T Laurencin; Lakshmi S Nair
Journal:  Acta Biomater       Date:  2018-05-25       Impact factor: 8.947

Review 7.  Central sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders.

Authors:  Lindsay L Kindler; Robert M Bennett; Kim D Jones
Journal:  Pain Manag Nurs       Date:  2009-12-02       Impact factor: 1.929

Review 8.  An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms.

Authors:  Mahmoud Slim; Elena Pita Calandre; Fernando Rico-Villademoros
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

Review 9.  Pathophysiology of fibromyalgia.

Authors:  Laurence A Bradley
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

10.  Altered T-UCRs expression profile in the spinal cord of mice with neuropathic pain.

Authors:  Bao-Chun Jiang; Tian Yang; Li-Na He; Yuan-Xiang Tao; Yong-Jing Gao
Journal:  Transl Perioper Pain Med       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.